Cara Therapeutics, Inc. (NASDAQ: CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common StockJuly 24, 2019 8:43 PM After-Hours Movers 07/24: (NTGR) (AINK) (MTH) Higher; (ALGN) (SAVE) (TSLA) (more...)July 24, 2019 6:02 PM Cara Therapeutics (CARA) Announces 5M Share Proposed Offering of Common StockJuly 24, 2019 4:42 PM